Reimbursement
7 September 2023
Miguel Forte, kicks off this
31 August 2023
BioMarin's ROCTAVIAN gene therapy has
POPULAR NEWS ITEMS
1 November 2024
Cell and Gene Therapies News Round-Up: November 1
30 October 2024
Shining the Spotlight on Texas Biotech Companies
23 October 2024
The Road to ATW: Cell and Gene Therapy Trends In Our 2025 Agenda
23 November 2022
Late-stage clinical trial company CellVax
24 August 2022
bluebird bio has announced that
21 June 2022
Lisa Deschamps, AviadoBio CEO and
21 June 2022
Phacilitate's Advanced Therapies Europe speaker